Cannabis Law Report

MAY 10, 2022

First comprehensive study reveals why Australians take medicinal cannabis. First academic study of national medicinal cannabis data. The first in-depth study of Australia’s medicinal cannabis program, which began in 2016, shows the drug is being increasingly prescribed for various conditions. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

JUNE 21, 2021

We conclude that in medical-only access models there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications with potentially impairing effects. Office of Medicinal Cannabis, Department of Health, Melbourne, VIC 3000, Australia.

Medicine 59

Medicine Safety Policy Treatment 59

Veriheal

MAY 31, 2022

With a worsening opioid situation and an emerging acceptance of medical cannabis, the Lone Star State has a unique opportunity to develop a successful medical marijuana (MMJ) program for its millions of residents battling chronic pain and numerous other conditions. Vital Changes to Texas’ Medical Cannabis Program.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Veriheal

APRIL 1, 2024

Cannabis is not legal in North Carolina for medicinal or recreational purposes yet, but one group has their own rules–the Eastern Band of Cherokee Indians (EBCI). When North Carolina launches its own medical cannabis program, all qualified state residents will be able to purchase products. The Great Smoky Cannabis Co.

Dispensary 106

Dispensary Chronic Pain Medicine History 106

Cannabis Law Report

MARCH 19, 2022

publishers announces the launch of Psychedelic Medicine , an influential and dynamic peer-reviewed journal supporting the growing influential research and clinical applications in this pivotal field. For further information or submission inquiries about Psychedelic Medicine , please contact us. Mary Ann Liebert Inc.,

Medicine 52

Medicine Decriminalization Pharmaceutical Topical 52

Cannabis Law Report

MARCH 9, 2022

Source: Clearmind Medicine Inc. TORONTO, March 08, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. About Clearmind Medicine Inc. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods or supplements. March 08, 2022 .

Medicine 52

Medicine Research and Development Pharmaceutical Treatment 52

Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. The researchers’ analysis found anxiety was the reason given for 16% of medicinal cannabis prescriptions. of prescriptions were for sleep disorders.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Cannabis Law Report

JANUARY 21, 2022

And if in 2020, the Minister of Health of Mauritius already announced to get to work , the Mauritian medical cannabis program is only beginning to take shape. Another important recommendation: only government-licensed or trained specialists will be allowed to prescribe cannabis-based medicines and provide treatment to patients.

Programs 52

Programs Patients Media THC 52

Sensi Seeds

JANUARY 4, 2019

Context of the Medicinal Cannabis Situation. Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). Under the regulations, no intermediaries are allowed to sell medicinal cannabis to patients. The Canadian Medical Association (CMA).

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Law Report

FEBRUARY 14, 2022

Our families and communities are suffering, and we urgently need access to preventative and curative medicines and medical care that is safe and effective. These ground-breaking treatments offer therapeutic access to either psilocybin (the active ingredient in ‘magic mushrooms’) or MDMA, a synthetic medicine.

Medicine 52

Medicine Access Therapy Treatment 52

Cannabis Law Report

OCTOBER 5, 2021

Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions. An evaluation of the therapeutic value, benefits and risks of methylenedioxymethamphetamine (MDMA) and psilocybin for the treatment of mental, behavioural or developmental disorders.

Treatment 52

Treatment Conditions Medicine Clinical Trials 52

Cannabis Law Report

JUNE 23, 2021

In addition to the pilot program, the parties are working toward an exclusive, definitive supply and distribution agreement, which, if entered into, is expected to position Medicann as the sole supplier and distributor of the RYAH Smart Dry Herb Inhalers in the region. has emerged as the largest supplier of medicinal cannabis in the world.

Programs 100

Programs Data Events Collective 100

Americans for Safe Access

JULY 29, 2020

Oregon is one of the few but growing number of states that have both a medical cannabis program and an adult use (recreational) program, and users of cannabis medicine can be found in either group. Of course having the conversation about cannabis can be complicated, intimidating and nerve racking.

Programs 169

Programs Therapy Medicine Patients 169

Veriheal

JULY 2, 2020

Louisiana has had a medical cannabis program for many years. In late May, Louisiana lawmakers discussed a bill that would significantly expand the state’s medical cannabis program and offer access to thousands of more patients in the state that may benefit from cannabinoid therapies. The Bill as Passed.

Banking 52

Banking Programs Therapy Conditions 52

Cannabis Law Report

JUNE 29, 2021

AUSTIN, Texas–(BUSINESS WIRE)– Texas Original Compassionate Cultivation (TOCC), Texas’ leading medical cannabis provider, says it will continue to advocate for an opioid alternative program as the opioid epidemic grips Texas. The Nucleus One report also explains how medical cannabis is a proven alternative to opioids.

Treatment 75

Treatment Cultivation Chronic Pain Programs 75

MMJ Recs

JANUARY 15, 2024

New Jersey Medical Marijuana Program Regulations In recent years, the landscape of medical marijuana has undergone significant transformations across the United States, and New Jersey has emerged as a trailblazer in implementing a robust Medicinal Cannabis Program (previously known as the Medicinal Marijuana Program).

Chronic Pain 52

Chronic Pain Marijuana Programs Conditions 52

SpeedWeed

JUNE 14, 2021

State officials tasked with overseeing Ohio’s medical marijuana program approved last week the addition of three health conditions that qualify a patient to use cannabis medicinally. The addition of all three, new, medical conditions to the Ohio Medical Marijuana Control Program (OMMCP) is effective immediately.

Conditions 40

Conditions Programs Therapy Patients 40

Cannabis Law Report

OCTOBER 20, 2021

The event will also feature a two-day pre-Summit Introductory Workshop Program (17-18 November) led by Nigel Denning, Dr Tra-ill Dowie with world-leading therapist trainer Dr Bill Richards (USA) from Johns Hopkins University. International Summit on Psychedelic Therapies for Mental Illness 17-20 November 2021.

Therapy 52

Therapy Medicine Topical Events 52

MMJ Recs

FEBRUARY 16, 2024

This article delves into the current status of medical marijuana in Texas, exploring the laws, regulations, qualifying conditions, and the overall framework that shapes the use of cannabis for medicinal purposes in the Lone Star State.

Legalization 52

Legalization Marijuana Dispensary Conditions 52

MMJ Recs

MARCH 8, 2024

Delving into Missouri’s medical marijuana program, this article offers an in-depth exploration of the costs associated with obtaining a medical card in Missouri. From understanding the program’s history and regulations to navigating the application process, we provide a comprehensive overview.

Access 52

Access Programs Patients Dispensary 52

Cannabis Law Report

JULY 28, 2021

InnarisBio), to develop a novel sol-gel intranasal drug delivery technology to improve treatments for mental health disorders. InnarisBio aims to be a revolutionary technology company for intranasal drug delivery in the treatment of CNS disorders. A potential solution is direct nose-to-brain delivery. About atai Life Sciences.

Research and Development 98

Research and Development Programs Treatment Media 98

NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”

Law 260

Law Patients Access Oil 260

Cannabis Law Report

JUNE 17, 2021

goodblend™ Texas , a retail brand of Parallel , one of the nation’s largest privately-held multi-state cannabis operators, today announced the launch of the first cannabinol (CBN) products for patients registered in the Texas Compassionate Use Program. goodblend™ Texas, a retail brand of Parallel.

Patients 97

Patients Programs Sleep Retail 97

SpeedWeed

JANUARY 25, 2019

Prescription painkiller addicts can now seek medical cannabis as a form of treatment in New Jersey. The state will also eliminate a prior authorization requirement for Medicaid recipients to receive medication-assisted treatment (MAT). 20, averaging nearly 7 deaths per day. link] pic.twitter.com/BTnNi5zfHd. Oscar Pascual.

Treatment 65

Treatment Marijuana Conditions Data 65

Cannabis Law Report

JULY 8, 2021

Many Australian consumers of medicinal cannabis access products that contain delta-9-tetrahydrocannabinol, better known as THC, which is a controlled drug under the Australian Poisons Standard, which provides a uniform approach to control the availability and accessibility of substances that can be used as ingredients in medicine. ‘A

Medicine 98

Medicine Research and Development Safety THC 98

Cannabis Law Report

DECEMBER 1, 2021

Ethics, Safety, and Abuse in Psychedelic Medicine. As psychedelic medicine becomes more mainstream, we must ensure that all who participate in healing therapeutic sessions, both above ground and in ceremonial or underground therapeutic settings, are safe and accessible to all. Wednesday, December 8th from 12:00-2:00pm PST.

Safety 52

Safety Medicine Therapy Research and Development 52

Canna Law Blog

MARCH 11, 2024

Medical cannabis is often the only effective treatment that allows them to function and improve their quality of life. Medical cannabis is already expensive and not covered by insurance or public health programs. It also goes against the principle of harm reduction, which is one basis of medical cannabis legalization policy.

Chronic Pain 104

Chronic Pain Recreational Patients Medicine 104

Cannabis Law Report

MARCH 2, 2020

The global march toward cannabis legalization has seemingly awoken another long dormant area of scientific interest: psychedelics as medicine. Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to Compass Pathways ‘ psilocybin therapy for treatment-resistant depression. What’s the risk?

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

Cannabis Law Report

JULY 29, 2021

These assets include 5 addiction treatment clinics across the province of Alberta that have conducted over 35,000 patient visits during the past 12 months. Each clinic employs a highly educated and specialized team of dedicated physicians, nurses and therapists working in unison with patients to ensure treatment goals are achieved.

Chronic Pain 105

Chronic Pain Treatment Therapy Patients 105

MMJ Recs

DECEMBER 10, 2023

While some states have embraced the therapeutic potential of cannabis and established robust medical marijuana programs, others lag behind, leaving patients without access to a potentially life-changing treatment. Disparities in access are primarily driven by the differing state regulations and policies surrounding medical marijuana.

Access 97

Access Marijuana Treatment Patients 97

Veriheal

FEBRUARY 21, 2023

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. To explore this issue further, let’s look at the key findings of this groundbreaking new research.

Access 98

Access Patients Chronic Pain Conditions 98

Cannabis Law Report

JUNE 12, 2021

Here we undertake an analysis of this policy issue based on a case study of the introduction of medicinal cannabis in Australia. Road safety risks associated with medicinal cannabis appear similar or lower than numerous other potentially impairing prescription medications. methadone) demonstrate a feasible alternative approach.

Policy 66

Policy Safety Medicine Access 66

Veriheal

AUGUST 24, 2022

The Colorado Secretary of State’s office announced earlier this month that the Natural Medicine Health Act received enough qualifying signatures to make it to this November’s ballot. The Natural Medicine Health Act: Pros and Cons. Not all alternative medicine advocates are in support of the Natural Medicine Health Act, however.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

MMJ Recs

DECEMBER 17, 2023

The Texas Compassionate Use Program (TCUP) represents the Lone Star State’s cautious foray into the realm of medical marijuana. Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals.

Law 52

Law Dispensary Clinical Trials Programs 52

SpeedWeed

MARCH 24, 2021

With the Eastern seaboard’s most ambitious Adult Use program primed to explode, New Jersey’s Superior Court Appellate Division (“Appellate Division”) just lifted its “stay” on scoring 18 month old Medical Marijuana applications clearing the way for 5 cultivation, 15 dispensary, and 4 vertically integrated license awards. Super. __ (App.

Programs 52

Programs Business Cannabis Retail 52

NORML

MAY 26, 2020

Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs.

Clinical Trials 251

Clinical Trials Chronic Pain Cannabinoids Patients 251

MMJ Recs

SEPTEMBER 16, 2023

Are you tired of battling chronic pain and searching for effective solutions to complement your MMJ treatment? Whether you’re looking for pain relief clinics in Detroit, MI, chronic pain Clinics in Grand Rapids, MI, or clinics in any other city in the state, you’ll find a ton of great non-surgical pain treatment options in Michigan.

Chronic Pain 52

Chronic Pain Patients Therapy Treatment 52